Hepion Pharmaceuticals Valuation
| HEPA Stock | USD 0.69 0.01 1.47% |
Hepion Pharmaceuticals is undervalued. Hepion Pharmaceuticals retains a regular Real Value of $6.41 per share. The prevalent price of the firm is $0.69. Our model calculates the value of Hepion Pharmaceuticals from evaluating the firm fundamentals such as Return On Asset of -0.93, shares owned by insiders of 0.08 %, and Return On Equity of -1.9 as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Hepion Pharmaceuticals' valuation include:
Price Book 2.1125 | Enterprise Value 7.3 M | Enterprise Value Ebitda (0.1) |
Undervalued
Today
Please note that Hepion Pharmaceuticals' price fluctuation is relatively risky at this time. Calculation of the real value of Hepion Pharmaceuticals is based on 3 months time horizon. Increasing Hepion Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Hepion Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Hepion Stock. However, Hepion Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.69 | Real 6.41 | Target 23.67 | Hype 0.69 | Naive 0.72 |
The real value of Hepion Stock, also known as its intrinsic value, is the underlying worth of Hepion Pharmaceuticals Company, which is reflected in its stock price. It is based on Hepion Pharmaceuticals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Hepion Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Hepion Pharmaceuticals helps investors to forecast how Hepion stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Hepion Pharmaceuticals more accurately as focusing exclusively on Hepion Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Hepion Pharmaceuticals' intrinsic value based on its ongoing forecasts of Hepion Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Hepion Pharmaceuticals' closest peers. If more than one evaluation category is relevant for Hepion Pharmaceuticals we suggest using both methods to arrive at a better estimate.
Hepion Pharmaceuticals Cash |
|
Hepion Valuation Trend
Comparing Hepion Pharmaceuticals' enterprise value against its market capitalization is a good way to estimate the value of Hepion Pharmaceuticals uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Hepion Pharmaceuticals Total Value Analysis
Hepion Pharmaceuticals is currently projected to have valuation of 7.25 M with market capitalization of 4.83 M, debt of 209.02 K, and cash on hands of 59.15 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Hepion Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
7.25 M | 4.83 M | 209.02 K | 59.15 M |
Hepion Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Hepion is to check how much profit was generated for every dollar of assets it reports. Hepion Pharmaceuticals retains a negative application of resources of -0.93 (percent), losing $0.009282 for each dollar of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each dollar of resources it retains. Simply put, asset utilization of Hepion Pharmaceuticals shows how discouraging it operates for each dollar spent on its resources.Hepion Pharmaceuticals Ownership Allocation
Roughly 92.07 (percent) of Hepion Pharmaceuticals outstanding shares are held by general public with 0.085 % owned by insiders and only 7.85 pct. by outside corporations.Hepion Pharmaceuticals Profitability Analysis
Net Loss for the year was (48.93 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Hepion Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Hepion Pharmaceuticals and how it compares across the competition.
About Hepion Pharmaceuticals Valuation
The stock valuation mechanism determines Hepion Pharmaceuticals' current worth on a weekly basis. Our valuation model uses a comparative analysis of Hepion Pharmaceuticals. We calculate exposure to Hepion Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Hepion Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -67.1 K | -70.5 K |
Hepion Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 4 M |
Hepion Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Hepion Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Hepion we look at many different elements of the entity such as Hepion's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Hepion Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Hepion Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Hepion Pharmaceuticals' worth.Complementary Tools for Hepion Stock analysis
When running Hepion Pharmaceuticals' price analysis, check to measure Hepion Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hepion Pharmaceuticals is operating at the current time. Most of Hepion Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hepion Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hepion Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hepion Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |